Hausdorff W P
Office of Health and Nutrition, US Agency for International Development, Washington, DC 20523, USA.
Vaccine. 1996 Sep;14(13):1179-86. doi: 10.1016/s0264-410x(96)00024-2.
Global immunization programs represent a great public health success story. Evidence from every region documents substantial reductions in morbidity and mortality following widespread use of vaccines developed years ago. Development and introduction of new vaccines and vaccine combinations aimed at the industrialized world market are occurring at a fast pace. A number of political and economic factors will influence the rate at which developing country immunization programs incorporate those new vaccines that could have a major public health impact. Perhaps the greatest determinant of this rate is the extent to which international and bilateral agencies and national governments appreciate the potential value of new vaccines.
全球免疫规划是公共卫生领域一个巨大的成功典范。每个地区的证据都表明，多年前研发的疫苗广泛使用后，发病率和死亡率大幅下降。针对工业化世界市场的新疫苗和疫苗组合正在迅速研发并投入使用。一些政治和经济因素将影响发展中国家免疫规划采用那些可能对公共卫生产生重大影响的新疫苗的速度。也许这一速度的最大决定因素是国际和双边机构以及各国政府对新疫苗潜在价值的认识程度。
